Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Firy Inc. (FIRY) vs Nuvalent Inc (NUVL) Price & Performance

Firy Inc.Trade
Nuvalent IncTrade

Price performance (Past 24H)

Key statistics

Firy Inc. vs Nuvalent Inc — how do they compare? Firy Inc. trades at $8.4 (market cap $125.48M), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Nuvalent Inc is far larger — about 78.2× Firy Inc.'s market cap, and Nuvalent Inc is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals.

FIRYNUVL
Market Cap
$125.48M$9.81B
Sector
Consumer CyclicalTechnology
52-Week High
$12.45$123.96
52-Week Low
$2.28$72.16
Enterprise Value
$69.16M$8.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Firy Inc.

FIRY trades at $8.39, up 4.35% today, with a bullish technical signal from moving averages and RSI near oversold levels. The company recently rebranded from Skillz Inc. and reported Q1 2026 revenue growth but continues significant losses, with a net income margin of -57.48%. Cash flow remains negative, though operating losses have narrowed from prior years.

Outlook is mixed: technical momentum and revenue stabilization offer potential upside, but persistent losses, negative cash flow, and weak profitability metrics pose substantial risks. Analyst consensus is neutral with 60% hold ratings, reflecting cautious optimism amid ongoing financial challenges.

Nuvalent Inc

Nuvalent (NUVL) trades at $123.96, unchanged on the day, with a P/B ratio of 8.35 and negative profitability metrics. The stock is technically bullish based on moving averages, though oscillators are neutral. Recent news highlights GSK's proposed acquisition of Nuvalent for $124 per share, totaling $10.6 billion, announced on June 9, 2026 (Reuters). Earnings have been mixed, with two misses and one beat in the last three quarters.

The acquisition by GSK provides a near-term price floor but limits upside. Risks include ongoing financial losses and shareholder litigation questioning deal fairness. Analyst sentiment is mixed with 42% buy ratings. The stock's outlook hinges on deal completion, with fundamental challenges persisting until closure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Firy Inc.

Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.

Read more on FIRY

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.

Read more on NUVL